Alzheimer’s disease develops when two abnormal proteins, amyloid plaques and tau tangles, gradually accumulate in the brain and destroy neurons over a period of decades. No single cause explains every case. For most people, Alzheimer’s results from a combination of age, genetics, and lifestyle factors that interact over a lifetime. About 1.7% of adults aged 65 to 74 have a dementia diagnosis, but that number climbs to 13.1% for those 85 and older.
What Happens Inside the Brain
The disease starts with a protein fragment called amyloid-beta. In a healthy brain, these fragments are produced and cleared away routinely. In Alzheimer’s, they clump together into sticky plaques that build up between neurons. These plaques don’t just sit there. Toxic forms of amyloid-beta trigger a second, more destructive process: they cause another protein called tau to become misshapen and tangle inside neurons themselves.
Tau normally helps maintain the internal scaffolding that neurons rely on to transport nutrients and signaling molecules to their endpoints. When tau tangles form, that scaffolding collapses. The supply lines running down nerve fibers disintegrate, cutting off the delivery of essential components to the synapses where brain cells communicate. This is the mechanism behind the memory loss and cognitive decline that define Alzheimer’s: synapses fail, neurons die, and entire brain regions shrink.
The brain’s own immune cells, called microglia, make things worse over time. Their job is to clear debris and protect neurons, but as amyloid accumulates, these immune cells shift into a chronically inflamed state. Instead of helping, they begin devouring healthy synapses, secreting toxic inflammatory signals, and even accelerating the spread of tau tangles from one brain region to another. A trio of inflammatory molecules released by these activated immune cells can flip nearby support cells into a neurotoxic mode that directly kills neurons. This self-reinforcing cycle of protein buildup, inflammation, and cell death is what makes Alzheimer’s progressive and, so far, irreversible.
The Role of Genetics
The strongest known genetic risk factor for the common, late-onset form of Alzheimer’s is a gene variant called APOE-e4. Between 15% and 25% of the population carries one copy, and 2% to 5% carry two. Having one copy raises your risk and is associated with developing the disease at a younger age. Carrying two copies raises the risk further. But APOE-e4 is not destiny: some people with two copies never develop Alzheimer’s, and many people who get the disease carry no copies at all.
A rarer form, called early-onset or familial Alzheimer’s, is caused by inherited mutations in one of three specific genes. These mutations are deterministic, meaning they virtually guarantee the disease will develop, typically around age 45 to 47, though onset can range from the early 30s to 60. This form accounts for a small fraction of all Alzheimer’s cases.
Cardiovascular Health in Midlife
What happens in your blood vessels in your 30s, 40s, and 50s appears to meaningfully shape your Alzheimer’s risk decades later. Research from the National Institute on Aging found that abnormal cholesterol and blood sugar levels as early as age 35 were associated with higher Alzheimer’s risk in older adulthood. Specifically, lower levels of HDL (“good”) cholesterol, higher triglycerides in early adulthood, and elevated blood sugar in middle age all contributed to future risk.
This connection makes biological sense. The brain consumes roughly 20% of the body’s blood supply. Conditions that damage blood vessels, including high blood pressure, high cholesterol, and diabetes, reduce blood flow to the brain and may impair its ability to clear amyloid and other waste products. The takeaway is that the cardiovascular choices you make in midlife don’t just protect your heart.
Sleep and Brain Waste Clearance
During deep sleep, your brain activates a waste-clearance system that flushes out metabolic byproducts, including amyloid-beta and tau. This system depends on the slow, synchronized brain waves that occur during non-REM sleep. Cerebrospinal fluid flows more freely through brain tissue during these phases, mixing with the fluid surrounding neurons and carrying away toxic proteins.
When sleep is chronically disrupted or insufficient, this clearance process slows down, and protein aggregation accelerates. The relationship likely runs both directions: poor sleep promotes the buildup of Alzheimer’s-related proteins, and those same proteins, as they accumulate, disrupt the brain circuits that regulate sleep. This creates a feedback loop that may begin years before any cognitive symptoms appear.
Air Pollution and Other Environmental Factors
Long-term exposure to fine particulate air pollution (PM2.5) is linked to higher rates of Alzheimer’s. A large national cohort study in the United States found that a standard increase in PM2.5 exposure was associated with a 9% increase in Alzheimer’s incidence. The components most strongly tied to risk were those related to traffic and fossil fuel combustion: sulfate particles, black carbon, and organic matter. The researchers found no safe threshold for black carbon, sulfate, or ammonium particles, meaning risk increased in a linear fashion with exposure.
Traumatic brain injury is another established environmental risk factor, particularly repeated head impacts. The mechanism likely involves both direct neuronal damage and the chronic inflammation that follows.
Modifiable Risk Factors You Can Address
A 2024 report from The Lancet Commission on dementia identified 14 modifiable risk factors that collectively account for a meaningful share of dementia cases worldwide. These span the entire lifespan:
- Earlier in life: less education, untreated hearing loss, untreated vision loss
- In midlife: hypertension, obesity, high LDL cholesterol, traumatic brain injury, excessive alcohol consumption (more than 12 US standard drinks per week)
- Later in life: smoking, depression, physical inactivity, diabetes, air pollution exposure, social isolation
None of these factors alone determines whether you’ll develop Alzheimer’s. But cumulatively, addressing them represents the most actionable strategy currently available. Regular exercise, staying socially connected, managing blood pressure and blood sugar, protecting your hearing and vision, avoiding excessive drinking, and minimizing exposure to air pollution all chip away at overall risk.
How Alzheimer’s Is Diagnosed
Alzheimer’s can now be diagnosed through biomarkers rather than symptoms alone. Updated 2024 diagnostic criteria incorporate blood-based tests alongside the traditional tools of brain imaging and cerebrospinal fluid analysis. These blood tests can detect the abnormal proteins associated with the disease with increasing accuracy, though they are currently recommended only for people already showing symptoms. Testing in people without cognitive complaints is not advised outside of research settings, partly because no approved treatments exist yet for the pre-symptomatic stage.
Imaging and fluid-based biomarkers within the same category are not interchangeable. A brain scan and a blood test may both look for amyloid, for instance, but they can yield different results in certain clinical scenarios. Diagnosis typically involves a combination of cognitive assessments, biomarker testing, and ruling out other causes of memory problems such as thyroid disorders, vitamin deficiencies, or depression.